Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): Emergence of multidrug-resistant clones less susceptible to cephalosporins

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Endimiani, Andrea ^a   Guilarte, Yuvia N ^a   Tinguely, Regula ^a   Hirzberger, Lea ^a   Selvini, Sylvia ^a   Lupo, Agnese ^a   Hauser, Christoph ^a   Furrer, Hansjakob ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Cefixime; Ceftriaxone; Gonococcus; MDR; MIC; Mosaic; NG MAST; PBP1; PBP2; ST1407

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; PENICILLIN DERIVATIVE; RNA 23S; SPECTINOMYCIN; TETRACYCLINE; ANTIINFECTIVE AGENT; CEPHALOSPORIN DERIVATIVE;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLA TEM GENE; CHILD; CLONAL VARIATION; CONTROLLED STUDY; EPSILOMETER TEST; ERMA GENE; ERMB GENE; ERMC GENE; ERMF GENE; FEMALE; GENE DELETION; GYRA GENE; HUMAN; MALE; MEFA GENE; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MTRR GENE; MULTIDRUG RESISTANCE; NEISSERIA GONORRHOEAE; NONHUMAN; NUCLEOTIDE SEQUENCE; PARC GENE; PENA GENE; PENB GENE; PENICILLIN RESISTANCE; PHENOTYPIC VARIATION; PONA GENE; PREVALENCE; PROMOTER REGION; RPLD GENE; RPLV GENE; SEQUENCE ANALYSIS; SWITZERLAND; TET(M) GENE; YOUNG ADULT; EPIDEMIOLOGY; GONORRHEA; INFANT; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; NEWBORN; PHENOTYPE; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GONORRHEA; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PENICILLINS; PHENOTYPE; SWITZERLAND; TETRACYCLINE; YOUNG ADULT;

EID: 84896706202     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-106     Document Type: Article

References (42)

1. World Health Organization (WHO) Department of Reproductive Health and Research. Global incidence and prevalence of selected curable sexually transmitted infections - 2008 2012, Geneva, Switzerland: WHO, World Health Organization (WHO).
2. World Health Organization (WHO) Department of Reproductive Health and Research. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae 2012, Geneva, Switzerland: WHO, World Health Organization (WHO).
3. Ison CA, Alexander S. Antimicrobial resistance in Neisseria gonorrhoeae in the UK: surveillance and management. Expert Rev Anti Infect Ther 2011, 9(10):867-876. 10.1586/eri.11.103, 21973299.
4. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol 2012, 7(12):1401-1422. 10.2217/fmb.12.117, 3629839, 23231489.
5. Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, Towns L, Lo S, Low DE, Melano RG. Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario. Canada. Antimicrob Agents Chemother 2011, 55(2):703-712.
6. Zhao L, Zhao S. TaqMan real-time quantitative PCR assay for detection of fluoroquinolone-resistant Neisseria gonorrhoeae. Curr Microbiol 2012, 65(6):692-695. 10.1007/s00284-012-0212-6, 22941436.
7. Chisholm SA, Dave J, Ison CA. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes. Antimicrob Agents Chemother 2010, 54(9):3812-3816. 10.1128/AAC.00309-10, 2935028, 20585125.
8. Chen SC, Yin YP, Dai XQ, Yu RX, Han Y, Sun HH, Ohnishi M, Unemo M, Chen XS. Prevalence and molecular epidemiological typing of penicillinase-producing Neisseria gonorrhoeae and their blaTEM-135 Gene Variants in Nanjing. China. Sex Transm Dis 2013, 40(11):872-876.
9. Warner DM, Shafer WM, Jerse AE. Clinically relevant mutations that cause derepression of the Neisseria gonorrhoeae MtrC-MtrD-MtrE Efflux pump system confer different levels of antimicrobial resistance and in vivo fitness. Mol Microbiol 2008, 70(2):462-478. 10.1111/j.1365-2958.2008.06424.x, 2602950, 18761689.
10. Shafer WM, Folster JP. Towards an understanding of chromosomally mediated penicillin resistance in Neisseria gonorrhoeae: evidence for a porin-efflux pump collaboration. J Bacteriol 2006, 188(7):2297-2299. 10.1128/JB.188.7.2297-2299.2006, 1428396, 16547015.
11. Camara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia. Spain. J Antimicrob Chemother 2012, 67(8):1858-1860.
12. Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012, 56(3):1273-1280. 10.1128/AAC.05760-11, 3294892, 22155830.
13. Chen CC, Yen MY, Wong WW, Li LH, Huang YL, Chen KW, Li SY. Tracing subsequent dissemination of a cluster of gonococcal infections caused by an ST1407-related clone harbouring mosaic penA alleles in Taiwan. J Antimicrob Chemother 2013, 68(7):1567-1571. 10.1093/jac/dkt059, 23508619.
14. Ohnishi M, Saika T, Hoshina S, Iwasaku K, Nakayama S, Watanabe H, Kitawaki J. Ceftriaxone-resistant Neisseria gonorrhoeae, Japan. Emerg Infect Dis 2011, 17(1):148-149. 10.3201/eid1701.100397, 3204624, 21192886.
15. Tomberg J, Unemo M, Ohnishi M, Davies C, Nicholas RA. Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041. Antimicrob Agents Chemother 2013, 57(7):3029-3036. 10.1128/AAC.00093-13, 3697319, 23587946.
16. Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 2007, 51(9):3111-3116. 10.1128/AAC.00306-07, 2043202, 17591846.
17. Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011, 55(7):3538-3545. 10.1128/AAC.00325-11, 3122416, 21576437.
18. Gonococcal Isolate Surveillance Project (GISP) U.S. Department of Health & Human Services - Public Health Service - Centers for Disease Control and Prevention (CDC) 2010, CDC, Gonococcal Isolate Surveillance Project (GISP).
19. European Centre for Diseases Prevention and Control (ECDC) Technical Report. Molecular typing of Neisseria gonorrhoeae. Results from a Pilot Study 2010-2011. Stockholm, 2012 2012, ECDC, European Centre for Diseases Prevention and Control (ECDC).
20. European Centre for Diseases Prevention and Control (ECDC) Surveillance Report. Gonococcal Antimicrobial Susceptibility Surveillance in Europe, 2011. Stockholm, 2013 2013, ECDC, European Centre for Diseases Prevention and Control (ECDC).
21. Shimuta K, Unemo M, Nakayama S, Morita-Ishihara T, Dorin M, Kawahata T, Ohnishi M. Antimicrobial Resistance and Molecular Typing of Neisseria gonorrhoeae Isolates in Kyoto and Osaka, Japan, 2010 to 2012: Intensified Surveillance after Identification of the First Strain (H041) with High-Level Ceftriaxone Resistance. Antimicrob Agents Chemother 2013, 57(11):5225-5232. 10.1128/AAC.01295-13, 23939890.
22. Ison CA, Town K, Obi C, Chisholm S, Hughes G, Livermore DM, Lowndes CM. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011. Lancet Infect Dis 2013, 13(9):762-768. 10.1016/S1473-3099(13)70143-9, 23764300.
23. Chisholm SA, Unemo M, Quaye N, Johansson E, Cole MJ, Ison CA, Van de Laar MJ. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Euro Surveill 2013, 18(3).
24. Martin I, Sawatzky P, Liu G, Allen V, Lefebvre B, Hoang L, Lovgren M, Haldane D, Caeseele PV, Horsman G, et al. Antimicrobial susceptibilities and distribution of sequence types of Neisseria gonorrhoeae isolates in Canada: 2010. Can J Microbiol 2013, 59(10):671-678. 10.1139/cjm-2013-0357, 24102220.
25. Mahon CR, Manuselis G. Textbook of Diagnostic Microbiology 2000, Philadelphia, Pennsylvania: W.B. Saunders Company, 2.
26. EUCAST European Committee on Antimicrobial Susceptibility Testing - Clinical breakpoints, Version 3.0, 2013 2013, EUCAST.
27. Martin IM, Ison CA, Aanensen DM, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis 2004, 189(8):1497-1505. 10.1086/383047, 15073688.
28. Hess D, Wu A, Golparian D, Esmaili S, Pandori W, Sena E, Klausner JD, Barry P, Unemo M, Pandori M. Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins. Antimicrob Agents Chemother 2012, 56(11):5633-5641. 10.1128/AAC.00636-12, 3486552, 22908152.
29. Takahashi S, Kurimura Y, Hashimoto J, Uehara T, Hiyama Y, Iwasawa A, Nishimura M, Sunaoshi K, Takeda K, Suzuki N, et al. Antimicrobial susceptibility and penicillin-binding protein 1 and 2 mutations in Neisseria gonorrhoeae isolated from male urethritis in Sapporo, Japan. J Infect Chemother 2013, 19(1):50-56. 10.1007/s10156-012-0450-3, 22797875.
30. Balashov S, Mordechai E, Adelson ME, Gygax SE. Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples. J Mol Diagn 2013, 15(1):116-129. 10.1016/j.jmoldx.2012.08.005, 23159594.
31. Le Lin B, Pastore R, Liassine N, Aramburu C, Sudre P. A new sexually transmitted infection (STI) in Geneva? Ciprofloxacin-resistant Neisseria gonorrhoeae, 2002-2005. Swiss Med Wkly 2008, 138(15-16):243-246.
32. Kovari H, de Melo Oliveira MD, Hauser P, Lauchli S, Meyer J, Weber R, Zbinden R. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012. BMC Infect Dis 2013, 13:603. 10.1186/1471-2334-13-603, 3881505, 24369054.
33. Ison CA, Hussey J, Sankar KN, Evans J, Alexander S. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Euro Surveill 2011, 16(14).
34. Unemo M, Golparian D, Syversen G, Vestrheim DF, Moi H. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Euro Surveill 2010, 15(47).
35. Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010. Euro Surveill 2011, 16(6).
36. Lewis DA, Sriruttan C, Muller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M. Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. J Antimicrob Chemother 2013, 68(6):1267-1270. 10.1093/jac/dkt034, 23416957.
37. Unemo M. The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy. Euro Surveill 2012, 17(47).
38. Heymans R, Bruisten SM, Golparian D, Unemo M, de Vries HJ, van Dam AP. Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam, the Netherlands. Antimicrob Agents Chemother 2012, 56(3):1516-1522. 10.1128/AAC.05481-11, 3294943, 22214779.
39. Allen VG, Mitterni L, Seah C, Rebbapragada A, Martin IE, Lee C, Siebert H, Towns L, Melano RG, Low DE. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto. Canada. Jama 2013, 309(2):163-170.
40. Nakayama S, Tribuddharat C, Prombhul S, Shimuta K, Srifuengfung S, Unemo M, Ohnishi M. Molecular analyses of TEM genes and their corresponding penicillinase-producing Neisseria gonorrhoeae isolates in Bangkok. Thailand. Antimicrob Agents Chemother 2012, 56(2):916-920.
41. Ohnishi M, Ono E, Shimuta K, Watanabe H, Okamura N. Identification of TEM-135 β-lactamase in penicillinase-producing Neisseria gonorrhoeae strains in Japan. Antimicrob Agents Chemother 2010, 54(7):3021-3023. 10.1128/AAC.00245-10, 2897271, 20421400.
42. Ng LK, Martin I, Liu G, Bryden L. Mutation in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2002, 46(9):3020-3025. 10.1128/AAC.46.9.3020-3025.2002, 127397, 12183262.